您当前的位置:
Betahistine 2HCl (Synonyms: 盐酸倍他司汀)
目录号: PC14204 纯度: ≥98%
CAS No. :5579-84-0
商品编号 规格 价格 会员价 是否有货 数量
PC14204-100mg 100mg ¥471.00 请登录
PC14204-1g 1g ¥611.00 请登录
PC14204-5g 5g ¥853.00 请登录
PC14204-10g 10g ¥1274.00 请登录
PC14204-10mM (in 1mL DMSO) 10mM (in 1mL DMSO) ¥637.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
Betahistine 2HCl
中文别名
盐酸倍他司汀;N-甲基-2-吡啶乙胺二盐酸盐;4-甲酰-1H-吡唑-5-羧酸;抗旋定;盐酸倍他司汀 EP标准品;盐酸倍他司汀 USP标准品;盐酸倍他司汀 标准品;盐酸倍他司汀及其杂质标准品;埃克替尼;倍他司汀二盐酸盐;倍他司汀盐酸盐;倍他司丁 二盐酸盐;N-甲基-2-吡啶乙胺 二盐酸盐
英文名称
Betahistine 2HCl
英文别名
2-(2-(Methylamino)ethyl)pyridine dihydrochloride;Betahistine dihydrochloride;Betahistine Hydrochloride;Betahistine;Betahistine (dihydrochloride);N-Methyl-2-pyridin-2-ylethanamine hydrochloride;N-methyl-2-pyridin-2-ylethanamine,dihydrochloride;Betahistine 2HCl;Serc;Betaserc;Antivom;Microser;Betahistine HCl;2-Pyridineethanamine, N-methyl-, dihydrochloride;PT-9;PT 9;beta-Histine dihdrochloride;Betahistine hydrochloride [USAN:USP];49K58SMZ7U;Betahistine dihdrochloride;N-methyl-N-(2-pyridin-2-ylethyl)amine dihydrochloride;C8H12N2.HCl;Novo-Betahistine;Methyl(2-[2-pyr
Cas No.
5579-84-0
分子式
C8H14Cl2N2
分子量
209.12
包装储存

4°C, protect from light, stored under nitrogen

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)

生物活性

Betahistine dihydrochloride is an orally active histamine H1 receptor agonist and a H3 receptor antagonist. Betahistine dihydrochloride is used for the study of rheumatoid arthritis (RA).

性状

Solid

IC50 & Target[1][2]

H3 Receptor

 

体外研究(In Vitro)

Betahistine dihydrochloride (0-10 μM) inhibits [I]iodoproxyfan binding to membranes of CHO (rH3(445)R) and CHO (hH3(445)R) cells with IC50 values of 1.9 μM and 3.3 μM, respectively. Lead to Ki values of 1.4 μM and 2.5 μM, respectively.
Betahistine dihydrochloride (0-10 μM) has a regulating function on cAMP formation in CHO (rH3(445)R), CHO (rH3(413)R), and CHO (hH3(445)R) cells. At low concentrations, betahistine behaves an apparent inverse agonist, and progressively enhances cAMP formation with EC50 values of 0.1 nM, 0.05 nM and 0.3 nM, respectively. In contrast, at concentrations higher than 10 nM, betahistine inhibits cAMP formation with an EC50 value of 0.1 μM in CHO (rH3(445)R) and full agonist activity.

Medlife has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究(In Vivo)

Betahistine dihydrochloride (intraperitoneal or oral administration; 0.1-30 mg/kg; single dose) with acute administration has increased tele-methylhistamine (t-MeHA) levels with an ED50 of 0.4 mg/kg, indicating the inverse agonism. Besides, after acute oral administration, it increases t-MeHA levels with an ED50 of 2 mg/kg in male Swissmice.
Betahistine dihydrochloride (oral adminstration; 1 and 5 mg/kg; daily for 3 weeks) attenuates the severity of arthritis and reduces the levels of pro-inflammatory cytokines in the paw tissues of CIA mice.

Medlife has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Collagen-induced arthritis (CIA) DBA/1 male mouse model
Dosage: 1 mg/kg; 5mg/kg
Administration: Oral adminstration; day 21 to day 42 after a 21-day CIA induction
Result: Ameliorated mouse CIA by decreasing joint destruction.
运输条件

Room temperature or refrigerated transportation.

储存方式

4°C, protect from light, stored under nitrogen

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)

ClinicalTrial
参考文献
溶解度数据
体外研究: 

H2O : ≥ 50 mg/mL (239.10 mM)

DMSO : 33.33 mg/mL (159.38 mM; Need ultrasonic)

DMF : 5 mg/mL (23.91 mM; Need ultrasonic)

* "≥" means soluble, but saturation unknown.

配制储备溶液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 4.7819 mL 23.9097 mL 47.8194 mL
5 mM 0.9564 mL 4.7819 mL 9.5639 mL
10 mM 0.4782 mL 2.3910 mL 4.7819 mL
*

产品不同,其溶解度不同。建议根据产品选择合适的溶剂配制储备溶液;配成溶液后,建议分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)。-80°C 储存时,建议在 6 个月内使用,-20°C 储存时,建议在 1 个月内使用。

体内研究:

建议根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都建议先按照 体外研究 方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    建议依照次序添加每种溶剂: PBS

    Solubility: 150 mg/mL (717.29 mM); Clear solution; Need ultrasonic

*
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

相关产品

更多
The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2